Dennis Cantellops Paite InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on Dennis Cantellops Paite, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through Feb 2023 and lists Dennis Cantellops Paite's inspections in 23 countries: China, Germany, Canada, United States, Ireland, Mexico, Argentina, United Kingdom, Austria, France, Netherlands, Spain, India, Slovenia, Italy, Belgium, Japan, Poland, Hungary, Switzerland, Denmark, Brazil, and Korea (the Republic of).

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Dennis Cantellops Paite's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Dennis Cantellops Paite.

Product details

• Dennis Cantellops Paite's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) Dennis Cantellops Paite has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Stefanie Heckman, Diane Goll, Christina Capacci-Daniel, Kumar Janoria, Libia Lugo, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.